It is provided a microspherical structure comprising an external shell of structured cellulose nanocrystals (CNCs) and at least one polymer, and a core, wherein the core can be hollow or filled with an immiscible medium. It is also provided a method for producing the same comprising spray-drying the mixture of CNCs and polymer through an atomizer and into a drying chamber forming droplets, wherein the solvent used to suspend the CNCs is evaporated and the microspherical structures are formed. These microstructural spheres can have wide industrial, medical and pharmaceutical applications, whereby their ingredients and structure are tuned and controlled.

A method of producing a resin modifier, the method comprising a process of polymerizing an ethylene unsaturated monomer in the presence of a cellulose nanofiber, the cellulose nanofiber being reacted with an amine or a quaternary ammonium salt compound.

The present invention relates to a thermoplastic resin composition comprising (A) 60 wt % to 75 wt % of a polycarbonate resin, (B) 5 wt % to 20 wt % of a polybutylene terephthalate resin, (C) 2 wt % to 8 wt % of a polyethylene terephthalate resin, (D) 1 wt % to 5 wt % of a methyl methacrylate-styrene-acrylonitrile copolymer, (E) 3 wt % to 8 wt % of an acrylonitrile-butadiene-styrene graft copolymer including a rubbery polymer having an average particle diameter of 200 nm to 400 nm, and (F) 5 wt % to 10 wt % of an acrylonitrile-butadiene-styrene copolymer including a rubbery polymer having an average particle diameter of 400 nm to 600 nm, and to a molded product using the same.

The present invention relates to a thermoplastic resin composition comprising (A) 60 wt % to 75 wt % of a polycarbonate resin, (B) 5 wt % to 20 wt % of a polybutylene terephthalate resin, (C) 2 wt % to 8 wt % of a polyethylene terephthalate resin, (D) 1 wt % to 5 wt % of a methyl methacrylate-styrene-acrylonitrile copolymer, (E) 3 wt % to 8 wt % of an acrylonitrile-butadiene-styrene graft copolymer including a rubbery polymer having an average particle diameter of 200 nm to 400 nm, and (F) 5 wt % to 10 wt % of an acrylonitrile-butadiene-styrene copolymer including a rubbery polymer having an average particle diameter of 400 nm to 600 nm, and to a molded product using the same.

A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.

A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.

A curable aqueous composition is disclosed comprising a carbohydrate, a crosslinking agent, and an amine base, wherein the curable aqueous composition has a pH adjusted by the amine base. Further disclosed is a method of forming a curable aqueous solution.

A curable aqueous composition is disclosed comprising a carbohydrate, a crosslinking agent, and an amine base, wherein the curable aqueous composition has a pH adjusted by the amine base. Further disclosed is a method of forming a curable aqueous solution.

The present invention provides an one-component (1K) anaerobic curable composition comprising, based on the weight of the composition:

from 15 to 35 wt. % of a1) at least one (meth)acrylate monomer represented by Formula I:

H.sub.2C═CGCO.sub.2R.sup.1   (I) wherein: G is hydrogen, halogen or a C.sub.1-C.sub.4 alkyl group; and, R.sup.1 is selected from C.sub.1-C.sub.30 alkyl, C.sub.3-C.sub.30 cycloalkyl, C.sub.2-C.sub.20 alkenyl and C.sub.2-C.sub.12 alkynyl;

from 5 to 25 wt. % of a2) at least one (meth)acrylate monomer represented by Formula II:

H.sub.2C═CQCO.sub.2R.sup.2   (II) wherein: Q may be hydrogen, halogen or a C.sub.1-C.sub.4 alkyl group; and, R.sup.2 may be selected from C.sub.6-C.sub.18 aryl, alkaryl and aralkyl;

from 35 to 75 wt. % of a3) at least one (meth)acrylate-functionalized oligomer;

from 0.1 to 10 wt. % of b) at least one cure initiator;

from 0.1 to 5 wt. % of c) at least one cure accelerator;

from 1 to 5 wt. % of d) at least one cellulose mixed ester of which all of said ester groups are selected from C.sub.1-C.sub.6 ester groups; and,

from 1 to 5 wt. % of e) fumed silica.

The present invention provides an one-component (1K) anaerobic curable composition comprising, based on the weight of the composition:

from 15 to 35 wt. % of a1) at least one (meth)acrylate monomer represented by Formula I:

H.sub.2C═CGCO.sub.2R.sup.1   (I) wherein: G is hydrogen, halogen or a C.sub.1-C.sub.4 alkyl group; and, R.sup.1 is selected from C.sub.1-C.sub.30 alkyl, C.sub.3-C.sub.30 cycloalkyl, C.sub.2-C.sub.20 alkenyl and C.sub.2-C.sub.12 alkynyl;

from 5 to 25 wt. % of a2) at least one (meth)acrylate monomer represented by Formula II:

H.sub.2C═CQCO.sub.2R.sup.2   (II) wherein: Q may be hydrogen, halogen or a C.sub.1-C.sub.4 alkyl group; and, R.sup.2 may be selected from C.sub.6-C.sub.18 aryl, alkaryl and aralkyl;

from 35 to 75 wt. % of a3) at least one (meth)acrylate-functionalized oligomer;

from 0.1 to 10 wt. % of b) at least one cure initiator;

from 0.1 to 5 wt. % of c) at least one cure accelerator;

from 1 to 5 wt. % of d) at least one cellulose mixed ester of which all of said ester groups are selected from C.sub.1-C.sub.6 ester groups; and,

from 1 to 5 wt. % of e) fumed silica.